nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—germ cell cancer—malignant glioma	0.823	1	CtDrD
Bleomycin—Lung fibrosis interstitial—Carmustine—malignant glioma	0.00921	0.143	CcSEcCtD
Bleomycin—LIG1—Mismatch repair—MSH2—malignant glioma	0.00624	0.09	CbGpPWpGaD
Bleomycin—LIG1—embryo—malignant glioma	0.00577	0.133	CbGeAlD
Bleomycin—LIG3—DNA Repair—MGMT—malignant glioma	0.00456	0.0658	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—MSH2—malignant glioma	0.00415	0.0598	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—MSH2—malignant glioma	0.00415	0.0598	CbGpPWpGaD
Bleomycin—BLMH—retina—malignant glioma	0.00412	0.095	CbGeAlD
Bleomycin—LIG1—MMR—MSH2—malignant glioma	0.00394	0.0568	CbGpPWpGaD
Bleomycin—BLMH—telencephalon—malignant glioma	0.00379	0.0874	CbGeAlD
Bleomycin—BLMH—medulla oblongata—malignant glioma	0.00298	0.0686	CbGeAlD
Bleomycin—LIG3—central nervous system—malignant glioma	0.00288	0.0664	CbGeAlD
Bleomycin—LIG3—cerebellum—malignant glioma	0.00282	0.0649	CbGeAlD
Bleomycin—BLMH—midbrain—malignant glioma	0.00272	0.0627	CbGeAlD
Bleomycin—LIG1—central nervous system—malignant glioma	0.00267	0.0615	CbGeAlD
Bleomycin—BLMH—spinal cord—malignant glioma	0.00266	0.0612	CbGeAlD
Bleomycin—LIG1—cerebellum—malignant glioma	0.00261	0.0601	CbGeAlD
Bleomycin—Pulmonary fibrosis—Carmustine—malignant glioma	0.00241	0.0375	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00233	0.0363	CcSEcCtD
Bleomycin—LIG1—Homologous Recombination Repair—BRCA2—malignant glioma	0.00232	0.0334	CbGpPWpGaD
Bleomycin—LIG3—brain—malignant glioma	0.00229	0.0528	CbGeAlD
Bleomycin—Myelosuppression—Carmustine—malignant glioma	0.00226	0.0352	CcSEcCtD
Bleomycin—Lung infiltration—Carmustine—malignant glioma	0.00226	0.0352	CcSEcCtD
Bleomycin—Myelosuppression—Temozolomide—malignant glioma	0.00219	0.034	CcSEcCtD
Bleomycin—BLMH—central nervous system—malignant glioma	0.00216	0.0497	CbGeAlD
Bleomycin—LIG3—DNA Repair—MSH2—malignant glioma	0.00212	0.0306	CbGpPWpGaD
Bleomycin—LIG1—brain—malignant glioma	0.00212	0.0488	CbGeAlD
Bleomycin—BLMH—cerebellum—malignant glioma	0.00211	0.0485	CbGeAlD
Bleomycin—Nephropathy toxic—Carmustine—malignant glioma	0.00185	0.0287	CcSEcCtD
Bleomycin—LIG1—Double-Strand Break Repair—BRCA2—malignant glioma	0.00182	0.0262	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Carmustine—malignant glioma	0.00178	0.0277	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MGMT—malignant glioma	0.00177	0.0255	CbGpPWpGaD
Bleomycin—Febrile neutropenia—Carmustine—malignant glioma	0.00176	0.0274	CcSEcCtD
Bleomycin—BLMH—brain—malignant glioma	0.00171	0.0394	CbGeAlD
Bleomycin—Febrile neutropenia—Temozolomide—malignant glioma	0.00171	0.0265	CcSEcCtD
Bleomycin—Interstitial lung disease—Carmustine—malignant glioma	0.0015	0.0233	CcSEcCtD
Bleomycin—Interstitial lung disease—Temozolomide—malignant glioma	0.00145	0.0225	CcSEcCtD
Bleomycin—LIG3—DNA Repair—BRCA2—malignant glioma	0.00131	0.0189	CbGpPWpGaD
Bleomycin—Hyperaesthesia—Temozolomide—malignant glioma	0.00131	0.0203	CcSEcCtD
Bleomycin—LIG1—Extension of Telomeres—TERT—malignant glioma	0.00125	0.0181	CbGpPWpGaD
Bleomycin—Extravasation—Carmustine—malignant glioma	0.00122	0.0189	CcSEcCtD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—malignant glioma	0.00121	0.0174	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—PARK2—malignant glioma	0.00104	0.0149	CbGpPWpGaD
Bleomycin—Skin exfoliation—Carmustine—malignant glioma	0.00101	0.0158	CcSEcCtD
Bleomycin—Skin exfoliation—Temozolomide—malignant glioma	0.000979	0.0152	CcSEcCtD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—HLA-C—malignant glioma	0.000931	0.0134	CbGpPWpGaD
Bleomycin—BLMH—Antigen processing: Ubiquitination & Proteasome degradation—FBXW7—malignant glioma	0.000908	0.0131	CbGpPWpGaD
Bleomycin—Phlebitis—Carmustine—malignant glioma	0.000894	0.0139	CcSEcCtD
Bleomycin—Injury—Carmustine—malignant glioma	0.000838	0.013	CcSEcCtD
Bleomycin—LIG1—DNA Repair—MSH2—malignant glioma	0.000824	0.0119	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00079	0.0114	CbGpPWpGaD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—FBXW7—malignant glioma	0.000779	0.0112	CbGpPWpGaD
Bleomycin—Pancytopenia—Carmustine—malignant glioma	0.000632	0.00983	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.000632	0.00911	CbGpPWpGaD
Bleomycin—Pancytopenia—Temozolomide—malignant glioma	0.000611	0.0095	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000599	0.00864	CbGpPWpGaD
Bleomycin—Pneumonia—Carmustine—malignant glioma	0.000597	0.00928	CcSEcCtD
Bleomycin—Weight decreased—Temozolomide—malignant glioma	0.000582	0.00905	CcSEcCtD
Bleomycin—Stomatitis—Carmustine—malignant glioma	0.000579	0.009	CcSEcCtD
Bleomycin—Pneumonia—Temozolomide—malignant glioma	0.000577	0.00897	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000568	0.00819	CbGpPWpGaD
Bleomycin—LIG1—Telomere Maintenance—TERT—malignant glioma	0.000568	0.00819	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TUBG2—malignant glioma	0.000565	0.00814	CbGpPWpGaD
Bleomycin—Stomatitis—Temozolomide—malignant glioma	0.000559	0.00869	CcSEcCtD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—HLA-B—malignant glioma	0.000551	0.00794	CbGpPWpGaD
Bleomycin—Haemoglobin—Carmustine—malignant glioma	0.000536	0.00833	CcSEcCtD
Bleomycin—Haemorrhage—Carmustine—malignant glioma	0.000533	0.00829	CcSEcCtD
Bleomycin—Hypoaesthesia—Carmustine—malignant glioma	0.00053	0.00824	CcSEcCtD
Bleomycin—Haemoglobin—Temozolomide—malignant glioma	0.000518	0.00805	CcSEcCtD
Bleomycin—Haemorrhage—Temozolomide—malignant glioma	0.000515	0.00801	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PARK2—malignant glioma	0.000513	0.0074	CbGpPWpGaD
Bleomycin—Hypoaesthesia—Temozolomide—malignant glioma	0.000513	0.00797	CcSEcCtD
Bleomycin—BLMH—Class I MHC mediated antigen processing & presentation—HLA-A—malignant glioma	0.00051	0.00736	CbGpPWpGaD
Bleomycin—LIG1—DNA Repair—BRCA2—malignant glioma	0.000509	0.00734	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000506	0.0073	CbGpPWpGaD
Bleomycin—Flushing—Carmustine—malignant glioma	0.000495	0.00769	CcSEcCtD
Bleomycin—Flushing—Temozolomide—malignant glioma	0.000478	0.00743	CcSEcCtD
Bleomycin—LIG1—Chromosome Maintenance—TERT—malignant glioma	0.000473	0.00682	CbGpPWpGaD
Bleomycin—Alopecia—Carmustine—malignant glioma	0.000471	0.00732	CcSEcCtD
Bleomycin—BLMH—Immune System—IL7—malignant glioma	0.000464	0.0067	CbGpPWpGaD
Bleomycin—Erythema—Carmustine—malignant glioma	0.000464	0.00721	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000463	0.00667	CbGpPWpGaD
Bleomycin—Chills—Temozolomide—malignant glioma	0.000462	0.00719	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—HLA-C—malignant glioma	0.000461	0.00665	CbGpPWpGaD
Bleomycin—Alopecia—Temozolomide—malignant glioma	0.000455	0.00708	CcSEcCtD
Bleomycin—Erythema—Temozolomide—malignant glioma	0.000448	0.00697	CcSEcCtD
Bleomycin—Anaemia—Carmustine—malignant glioma	0.000429	0.00667	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—CTSB—malignant glioma	0.000428	0.00617	CbGpPWpGaD
Bleomycin—Ill-defined disorder—Temozolomide—malignant glioma	0.000416	0.00647	CcSEcCtD
Bleomycin—Leukopenia—Carmustine—malignant glioma	0.000415	0.00646	CcSEcCtD
Bleomycin—Anaemia—Temozolomide—malignant glioma	0.000414	0.00644	CcSEcCtD
Bleomycin—BLMH—Immune System—CFH—malignant glioma	0.000407	0.00587	CbGpPWpGaD
Bleomycin—Malaise—Temozolomide—malignant glioma	0.000404	0.00629	CcSEcCtD
Bleomycin—Leukopenia—Temozolomide—malignant glioma	0.000401	0.00624	CcSEcCtD
Bleomycin—Chest pain—Carmustine—malignant glioma	0.000395	0.00614	CcSEcCtD
Bleomycin—Myalgia—Carmustine—malignant glioma	0.000395	0.00614	CcSEcCtD
Bleomycin—Cough—Temozolomide—malignant glioma	0.000391	0.00608	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FBXW7—malignant glioma	0.000386	0.00556	CbGpPWpGaD
Bleomycin—Confusional state—Carmustine—malignant glioma	0.000382	0.00594	CcSEcCtD
Bleomycin—Myalgia—Temozolomide—malignant glioma	0.000382	0.00593	CcSEcCtD
Bleomycin—Oedema—Carmustine—malignant glioma	0.000379	0.00589	CcSEcCtD
Bleomycin—Discomfort—Temozolomide—malignant glioma	0.000377	0.00586	CcSEcCtD
Bleomycin—Infection—Carmustine—malignant glioma	0.000376	0.00585	CcSEcCtD
Bleomycin—Thrombocytopenia—Carmustine—malignant glioma	0.000371	0.00576	CcSEcCtD
Bleomycin—Confusional state—Temozolomide—malignant glioma	0.000369	0.00574	CcSEcCtD
Bleomycin—Anaphylactic shock—Temozolomide—malignant glioma	0.000366	0.00569	CcSEcCtD
Bleomycin—Oedema—Temozolomide—malignant glioma	0.000366	0.00569	CcSEcCtD
Bleomycin—Infection—Temozolomide—malignant glioma	0.000364	0.00565	CcSEcCtD
Bleomycin—Anorexia—Carmustine—malignant glioma	0.000361	0.00561	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00036	0.00519	CbGpPWpGaD
Bleomycin—Thrombocytopenia—Temozolomide—malignant glioma	0.000358	0.00557	CcSEcCtD
Bleomycin—Hypotension—Carmustine—malignant glioma	0.000354	0.0055	CcSEcCtD
Bleomycin—Anorexia—Temozolomide—malignant glioma	0.000349	0.00542	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000345	0.00536	CcSEcCtD
Bleomycin—Paraesthesia—Carmustine—malignant glioma	0.00034	0.00529	CcSEcCtD
Bleomycin—Dyspnoea—Carmustine—malignant glioma	0.000338	0.00525	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000335	0.00483	CbGpPWpGaD
Bleomycin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000333	0.00518	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000332	0.00478	CbGpPWpGaD
Bleomycin—Decreased appetite—Carmustine—malignant glioma	0.000329	0.00512	CcSEcCtD
Bleomycin—Paraesthesia—Temozolomide—malignant glioma	0.000329	0.00511	CcSEcCtD
Bleomycin—Dyspnoea—Temozolomide—malignant glioma	0.000326	0.00507	CcSEcCtD
Bleomycin—Pain—Carmustine—malignant glioma	0.000324	0.00503	CcSEcCtD
Bleomycin—Decreased appetite—Temozolomide—malignant glioma	0.000318	0.00495	CcSEcCtD
Bleomycin—Pain—Temozolomide—malignant glioma	0.000313	0.00487	CcSEcCtD
Bleomycin—Feeling abnormal—Carmustine—malignant glioma	0.000312	0.00485	CcSEcCtD
Bleomycin—BLMH—Immune System—PARK2—malignant glioma	0.000311	0.00449	CbGpPWpGaD
Bleomycin—BLMH—Immune System—LGALS3—malignant glioma	0.000311	0.00449	CbGpPWpGaD
Bleomycin—Feeling abnormal—Temozolomide—malignant glioma	0.000302	0.00469	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000301	0.00434	CbGpPWpGaD
Bleomycin—Body temperature increased—Carmustine—malignant glioma	0.000299	0.00465	CcSEcCtD
Bleomycin—Urticaria—Temozolomide—malignant glioma	0.000291	0.00452	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—PLK1—malignant glioma	0.00029	0.00418	CbGpPWpGaD
Bleomycin—Body temperature increased—Temozolomide—malignant glioma	0.000289	0.0045	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	0.000287	0.00414	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HLA-C—malignant glioma	0.00028	0.00403	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PML—malignant glioma	0.00028	0.00403	CbGpPWpGaD
Bleomycin—Hypersensitivity—Carmustine—malignant glioma	0.000279	0.00434	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—PDGFRA—malignant glioma	0.000274	0.00396	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HLA-B—malignant glioma	0.000273	0.00393	CbGpPWpGaD
Bleomycin—Asthenia—Carmustine—malignant glioma	0.000272	0.00422	CcSEcCtD
Bleomycin—Hypersensitivity—Temozolomide—malignant glioma	0.00027	0.00419	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000269	0.00388	CbGpPWpGaD
Bleomycin—Asthenia—Temozolomide—malignant glioma	0.000263	0.00408	CcSEcCtD
Bleomycin—BLMH—Immune System—CTSB—malignant glioma	0.00026	0.00374	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—PLK1—malignant glioma	0.000259	0.00374	CbGpPWpGaD
Bleomycin—Pruritus—Temozolomide—malignant glioma	0.000259	0.00403	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—HIST1H3B—malignant glioma	0.000257	0.0037	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—HLA-A—malignant glioma	0.000253	0.00364	CbGpPWpGaD
Bleomycin—LIG1—HIV Infection—HLA-A—malignant glioma	0.000251	0.00362	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PDGFB—malignant glioma	0.000247	0.00356	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—FGFR1—malignant glioma	0.000245	0.00354	CbGpPWpGaD
Bleomycin—BLMH—Immune System—DUSP6—malignant glioma	0.000242	0.00349	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000241	0.00348	CbGpPWpGaD
Bleomycin—Vomiting—Carmustine—malignant glioma	0.000241	0.00374	CcSEcCtD
Bleomycin—Rash—Carmustine—malignant glioma	0.000239	0.00371	CcSEcCtD
Bleomycin—Dermatitis—Carmustine—malignant glioma	0.000239	0.00371	CcSEcCtD
Bleomycin—BLMH—Immune System—FBXW7—malignant glioma	0.000234	0.00337	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000234	0.00337	CbGpPWpGaD
Bleomycin—Vomiting—Temozolomide—malignant glioma	0.000233	0.00362	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000231	0.00333	CbGpPWpGaD
Bleomycin—Rash—Temozolomide—malignant glioma	0.000231	0.00359	CcSEcCtD
Bleomycin—Dermatitis—Temozolomide—malignant glioma	0.000231	0.00358	CcSEcCtD
Bleomycin—Nausea—Carmustine—malignant glioma	0.000225	0.0035	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—TOP2A—malignant glioma	0.000224	0.00323	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—H3F3A—malignant glioma	0.000222	0.0032	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—BAD—malignant glioma	0.00022	0.00317	CbGpPWpGaD
Bleomycin—Nausea—Temozolomide—malignant glioma	0.000217	0.00338	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—YWHAE—malignant glioma	0.000214	0.00308	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD80—malignant glioma	0.000213	0.00307	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—EGF—malignant glioma	0.00021	0.00303	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PTPN11—malignant glioma	0.000209	0.00302	CbGpPWpGaD
Bleomycin—LIG1—Disease—BCAN—malignant glioma	0.000206	0.00298	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNA2—malignant glioma	0.000204	0.00295	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TOP2A—malignant glioma	0.0002	0.00289	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—H3F3A—malignant glioma	0.000198	0.00286	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000197	0.00284	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT2—malignant glioma	0.000195	0.00281	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—YWHAE—malignant glioma	0.000191	0.00276	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CD—malignant glioma	0.000187	0.0027	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000187	0.00269	CbGpPWpGaD
Bleomycin—LIG1—Disease—DTX1—malignant glioma	0.000187	0.00269	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000184	0.00265	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000183	0.00264	CbGpPWpGaD
Bleomycin—LIG1—S Phase—MYC—malignant glioma	0.000183	0.00264	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000181	0.00262	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—FGF2—malignant glioma	0.000179	0.00258	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTK2—malignant glioma	0.000178	0.00257	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000177	0.00256	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—MDM2—malignant glioma	0.000168	0.00242	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—RAF1—malignant glioma	0.000167	0.00241	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PDGFRA—malignant glioma	0.000166	0.0024	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HLA-B—malignant glioma	0.000165	0.00238	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—ERBB2—malignant glioma	0.000165	0.00238	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000165	0.00237	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CB—malignant glioma	0.000163	0.00235	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2B—malignant glioma	0.000161	0.00232	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000155	0.00223	CbGpPWpGaD
Bleomycin—BLMH—Immune System—HLA-A—malignant glioma	0.000153	0.00221	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PDGFB—malignant glioma	0.00015	0.00216	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGFR1—malignant glioma	0.000149	0.00215	CbGpPWpGaD
Bleomycin—LIG1—Disease—HEY2—malignant glioma	0.000146	0.00211	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—BRCA2—malignant glioma	0.000145	0.00209	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN2B—malignant glioma	0.000144	0.00207	CbGpPWpGaD
Bleomycin—LIG1—Disease—IDH1—malignant glioma	0.000143	0.00206	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PTEN—malignant glioma	0.000141	0.00203	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00014	0.00201	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—BIRC5—malignant glioma	0.000139	0.002	CbGpPWpGaD
Bleomycin—LIG1—Disease—HEY1—malignant glioma	0.000136	0.00196	CbGpPWpGaD
Bleomycin—BLMH—Immune System—BAD—malignant glioma	0.000133	0.00192	CbGpPWpGaD
Bleomycin—LIG1—Disease—HIST1H3B—malignant glioma	0.000132	0.0019	CbGpPWpGaD
Bleomycin—BLMH—Immune System—CD80—malignant glioma	0.000129	0.00186	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000129	0.00185	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EGF—malignant glioma	0.000128	0.00184	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTPN11—malignant glioma	0.000127	0.00183	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000126	0.00181	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—BIRC5—malignant glioma	0.000124	0.00179	CbGpPWpGaD
Bleomycin—LIG1—Disease—JAG2—malignant glioma	0.00012	0.00173	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TERT—malignant glioma	0.00012	0.00173	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00012	0.00173	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000119	0.00171	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT2—malignant glioma	0.000118	0.0017	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—EGFR—malignant glioma	0.000115	0.00165	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CD—malignant glioma	0.000113	0.00164	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000109	0.00157	CbGpPWpGaD
Bleomycin—BLMH—Immune System—FGF2—malignant glioma	0.000109	0.00157	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—KRAS—malignant glioma	0.000108	0.00156	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000106	0.00152	CbGpPWpGaD
Bleomycin—BLMH—Immune System—BCL2—malignant glioma	0.000103	0.00149	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IFNG—malignant glioma	0.000102	0.00147	CbGpPWpGaD
Bleomycin—LIG1—Disease—H3F3A—malignant glioma	0.000102	0.00147	CbGpPWpGaD
Bleomycin—BLMH—Immune System—MDM2—malignant glioma	0.000102	0.00147	CbGpPWpGaD
Bleomycin—BLMH—Immune System—RAF1—malignant glioma	0.000101	0.00146	CbGpPWpGaD
Bleomycin—BLMH—Immune System—ERBB2—malignant glioma	0.0001	0.00145	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—PIK3CA—malignant glioma	9.94e-05	0.00143	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CB—malignant glioma	9.89e-05	0.00143	CbGpPWpGaD
Bleomycin—LIG1—Disease—JAG1—malignant glioma	9.6e-05	0.00138	CbGpPWpGaD
Bleomycin—LIG1—Disease—FBXW7—malignant glioma	9.4e-05	0.00136	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—malignant glioma	9.18e-05	0.00132	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL1B—malignant glioma	9.12e-05	0.00131	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL2—malignant glioma	9.08e-05	0.00131	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	8.92e-05	0.00129	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PTEN—malignant glioma	8.55e-05	0.00123	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—CDKN2A—malignant glioma	8.21e-05	0.00118	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—AKT1—malignant glioma	8.12e-05	0.00117	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MDM2—malignant glioma	7.96e-05	0.00115	CbGpPWpGaD
Bleomycin—BLMH—Immune System—STAT3—malignant glioma	7.64e-05	0.0011	CbGpPWpGaD
Bleomycin—LIG1—Disease—CDKN2B—malignant glioma	7.37e-05	0.00106	CbGpPWpGaD
Bleomycin—LIG1—Disease—HES1—malignant glioma	7.03e-05	0.00101	CbGpPWpGaD
Bleomycin—LIG1—Disease—NCOR1—malignant glioma	6.99e-05	0.00101	CbGpPWpGaD
Bleomycin—BLMH—Immune System—EGFR—malignant glioma	6.95e-05	0.001	CbGpPWpGaD
Bleomycin—LIG1—Disease—PDGFRA—malignant glioma	6.69e-05	0.000965	CbGpPWpGaD
Bleomycin—BLMH—Immune System—KRAS—malignant glioma	6.56e-05	0.000946	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—MYC—malignant glioma	6.22e-05	0.000897	CbGpPWpGaD
Bleomycin—LIG1—Disease—TERT—malignant glioma	6.16e-05	0.000888	CbGpPWpGaD
Bleomycin—LIG1—Disease—HLA-A—malignant glioma	6.16e-05	0.000888	CbGpPWpGaD
Bleomycin—BLMH—Immune System—PIK3CA—malignant glioma	6.03e-05	0.00087	CbGpPWpGaD
Bleomycin—LIG1—Disease—PDGFB—malignant glioma	6.01e-05	0.000867	CbGpPWpGaD
Bleomycin—LIG1—Disease—FGFR1—malignant glioma	5.98e-05	0.000862	CbGpPWpGaD
Bleomycin—LIG1—Disease—HIF1A—malignant glioma	5.89e-05	0.000849	CbGpPWpGaD
Bleomycin—LIG1—Disease—CAV1—malignant glioma	5.7e-05	0.000821	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—MYC—malignant glioma	5.56e-05	0.000802	CbGpPWpGaD
Bleomycin—LIG1—Disease—BAD—malignant glioma	5.36e-05	0.000772	CbGpPWpGaD
Bleomycin—LIG1—Disease—NOTCH1—malignant glioma	5.31e-05	0.000765	CbGpPWpGaD
Bleomycin—LIG1—Disease—CD80—malignant glioma	5.2e-05	0.000749	CbGpPWpGaD
Bleomycin—LIG1—Disease—APC—malignant glioma	5.19e-05	0.000748	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGF—malignant glioma	5.13e-05	0.000739	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTPN11—malignant glioma	5.1e-05	0.000735	CbGpPWpGaD
Bleomycin—BLMH—Immune System—AKT1—malignant glioma	4.93e-05	0.00071	CbGpPWpGaD
Bleomycin—LIG1—Disease—BRAF—malignant glioma	4.88e-05	0.000703	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT2—malignant glioma	4.75e-05	0.000684	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—TP53—malignant glioma	4.57e-05	0.000659	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CD—malignant glioma	4.56e-05	0.000658	CbGpPWpGaD
Bleomycin—LIG1—Disease—FGF2—malignant glioma	4.37e-05	0.00063	CbGpPWpGaD
Bleomycin—LIG1—Disease—MDM2—malignant glioma	4.09e-05	0.000589	CbGpPWpGaD
Bleomycin—LIG1—Disease—RAF1—malignant glioma	4.07e-05	0.000587	CbGpPWpGaD
Bleomycin—LIG1—Disease—ERBB2—malignant glioma	4.03e-05	0.000581	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CB—malignant glioma	3.98e-05	0.000573	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—malignant glioma	3.94e-05	0.000568	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTEN—malignant glioma	3.44e-05	0.000495	CbGpPWpGaD
Bleomycin—LIG1—Disease—STAT3—malignant glioma	3.07e-05	0.000443	CbGpPWpGaD
Bleomycin—LIG1—Disease—MYC—malignant glioma	2.85e-05	0.000412	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—malignant glioma	2.79e-05	0.000403	CbGpPWpGaD
Bleomycin—LIG1—Disease—KRAS—malignant glioma	2.64e-05	0.00038	CbGpPWpGaD
Bleomycin—LIG1—Disease—PIK3CA—malignant glioma	2.42e-05	0.000349	CbGpPWpGaD
Bleomycin—LIG1—Disease—AKT1—malignant glioma	1.98e-05	0.000285	CbGpPWpGaD
